Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Internal site version update from v3.2.0 to v3.3.2 with no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:17:53.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A notice about government funding lapses and potential delays in updates and inquiries has been removed from the page. The NIH Clinical Center's operating status and data currency warnings are no longer displayed.
    Difference
    0.4%
    Check dated 2025-11-17T19:14:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Updated results section now includes primary and secondary outcomes and there are revised contact and location details for participating sites.
    Difference
    0.4%
    Check dated 2025-11-03T13:47:05.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Updated to v3.2.0 with an added government operating-status notice; removed the specific topic Medullary thyroid carcinoma (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T04:14:12.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Updated the disease name to a streamlined term and bumped the revision to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T23:35:08.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed; overall, there are no substantive changes to core content.
    Difference
    0.1%
    Check dated 2025-09-14T09:52:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.